Rafferty Asset Management, LLC Amneal Pharmaceuticals, Inc. Transaction History
Rafferty Asset Management, LLC
- $27.6 Billion
- Q4 2024
A detailed history of Rafferty Asset Management, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 15,663 shares of AMRX stock, worth $129,689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,663
Previous 18,844
16.88%
Holding current value
$129,689
Previous $156,000
20.51%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
124MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$123 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$102 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$93.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$88.8 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$74.4 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.25B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...